News for Altamira Therapeutics Ltd. (CYTO)

**media[521681]**

**media[503378]**

**media[497747]**

Altamira Therapeutics Provides Update on Nasdaq Listing

Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray

Earnings call: Altamira Therapeutics focuses on RNA delivery growth

Total Operating Loss from Continuing Operations: $3.9 million in H1 2024, compared to $3.6 million in H1 2023.Research and Development Expenditures: Increased

Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q2 2024 Results Conference Call September 24, 2024 8:30 AM ETCompany ParticipantsThomas Meyer - Founder, Chairman...

Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed request for marketing authorization for Mainland China Extension of Exclusive License and Distribution Agreement to include seven additional countries across East and South East Asia with cumulated population > 630 million SHANGHAI, Sept. 23, 2024 /PRNewswire/ -- Nuance Pharma (the 'Company') today announced that it has agreed with Altamira Medica Ltd., an associate company of Altamira Therapeutics Ltd. (Nasdaq:CYTO), to extend the territory covered by the exclusive license and distribution agreement for Bentrio® nasal spray by several countries across South East and East Asia. Under the amended agreement, Nuance's territory will expand from China (Mainland, Hong Kong, Macau) and South Korea to also include Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam and Taiwan, with a combined population of greater than 630 million people. Nuance has been marketing Bentrio in Hong Kong since late 2022 and recently submitted the request for marketing approval for Mainland China.

Nuance Pharma expands Bentrio nasal spray distribution in Asia

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.01%

/PRNewswire/ -- The vertigo drugs market size is expected to grow by USD 551.42 million from 2022 to 2027. In addition, the momentum of the market will...

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.00 A.M. ET)..

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.00 A.M. ET)..

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. Following the market opening Friday, the Dow traded up 0.42% to 33,140.85 while the NASDAQ rose 1.02% to 11,579.87. The S&P 500 also rose, gaining, 0.72% to 4,010.13.